169 related articles for article (PubMed ID: 7191298)
1. Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry.
Reiterer W
Arzneimittelforschung; 1980; 30(7):1147-53. PubMed ID: 7191298
[TBL] [Abstract][Full Text] [Related]
2. Experience with a slow-release formulation of oxprenolol.
Waal-Manning HJ; Spears GF
N Z Med J; 1978 Apr; 87(609):245-6. PubMed ID: 275650
[TBL] [Abstract][Full Text] [Related]
3. [Effect of oxprenolol on the dynamics of left ventricular contraction in patients with coronary disease].
Hoszowski K; Prosińska-Kibler M
Kardiol Pol; 1972; 15(4):433-6. PubMed ID: 4641913
[No Abstract] [Full Text] [Related]
4. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise.
Bobik A; Jennings GL; Korner PI; Ashley P; Jackman G
Br J Clin Pharmacol; 1979 Jun; 7(6):545-9. PubMed ID: 465276
[TBL] [Abstract][Full Text] [Related]
5. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
[TBL] [Abstract][Full Text] [Related]
6. Effect of pedal rate on diurnal variations in cardiorespiratory variables.
Bessot N; Moussay S; Gauthier A; Larue J; Sesboüe B; Davenne D
Chronobiol Int; 2006; 23(4):877-87. PubMed ID: 16887754
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
Kerr MJ; Harron DW; Kinney C; Shanks RG
Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
Bennett PN; Bennett J; Bradbrook I; Francis J; John VA; Rogers H; Turner P; Warrington SJ
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119
[TBL] [Abstract][Full Text] [Related]
9. Low intensity physical conditioning: effects on patients with coronary heart disease.
Franklin BA; Besseghini I; Golden LH
Arch Phys Med Rehabil; 1978 Jun; 59(6):276-80. PubMed ID: 666558
[TBL] [Abstract][Full Text] [Related]
10. [The exercise test with atropine].
Variola A; Albiero R; Dander B; Buonanno C
G Ital Cardiol; 1997 Mar; 27(3):255-62. PubMed ID: 9244727
[TBL] [Abstract][Full Text] [Related]
11. The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.
Koopmans R; Oosterhuis B; Karemaker JM; Wemer J; van Boxtel CJ
Eur J Clin Pharmacol; 1993; 44(2):171-6. PubMed ID: 8453962
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and dynamics of oxprenolol: a simulation study with six subjects.
Saunders L; Ingram D; Warrington SJ
J Pharm Pharmacol; 1985 Nov; 37(11):802-6. PubMed ID: 2867161
[TBL] [Abstract][Full Text] [Related]
13. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
van Baak MA; Verstappen FT; Oosterhuis B
Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
[TBL] [Abstract][Full Text] [Related]
15. Effect of physical training on exercise performance of children following surgical repair of congenital heart disease.
Goldberg B; Fripp RR; Lister G; Loke J; Nicholas JA; Talner NS
Pediatrics; 1981 Nov; 68(5):691-9. PubMed ID: 7312473
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.
Aellig WH
Eur J Clin Pharmacol; 1978 Nov; 14(3):167-9. PubMed ID: 729611
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockade and exercise capacity in patients with mitral stenosis in sinus rhythm.
Monmeneu Menadas JV; Marín Ortuño F; Reyes Gomis F; Jordán Torrent A; García Martínez M; Bodí Peris V; García de Burgos de Rico E
J Heart Valve Dis; 2002 Mar; 11(2):199-203. PubMed ID: 12000160
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
[TBL] [Abstract][Full Text] [Related]
19. [Cardiopulmonary capacity in patients with coronary heart disease].
Winter UJ; Gitt AK; Blaum M; Fritsch J; Berge PG; Pothoff G; Hilger HH
Z Kardiol; 1994; 83 Suppl 3():73-82. PubMed ID: 7941676
[TBL] [Abstract][Full Text] [Related]
20. Effect of Metoprolol CR/XL on pulmonary artery pressure in chronic heart failure patients assessed by an implanted ultrasonic device with special emphasis on diurnal variation and exercise capacity.
Parikh KH; Hetal A; Milan C; Urmil G; Hemang A; Anish C; Ajay M; Ake H; Ramesh K; Parloop A; Rozenman Y
Indian Heart J; 2009; 61(1):34-9. PubMed ID: 19729686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
